BLITZ Atrial Fibrillation

Overview

Management strategies for AF have made many advances over the last decade but there is still a great heterogeneity in the management of AF and it remains unclear how often clinicians adhere to current guidelines.

A survey of an updated AF management would enable a timely assessment of implementation of current International guidelines, allow monitoring of early management of AF when a patients is admitted in a Emergency Room (ER) and Cardiology Unit.

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 30, 2016

Detailed Description

Multicentre, observational study. 200 Italian Hospitals fully representing the Italian cardiology reality in terms of geographical distribution and level of hospital technology.

Data collection in ER: Data on AF and Atrial Flutter episodes in ER will be collected retrospectively by checking the records of ER without collection of any data that can allow to identify the patients. These data will be collected under the responsibility of the Cardiology Departments consecutively for 4 weeks.

Data collected in Cardiology: these data will be collected under the responsibility of the Cardiology Departments for 12 weeks consecutively.

Interventions

  • Other: Atrial Fibrillation
    • Data collection on Atrial Fibrillation

Arms, Groups and Cohorts

  • AF patients
    • Patients with Atrial Fibrillation

Clinical Trial Outcome Measures

Primary Measures

  • Number of admissions of patients with AF
    • Time Frame: Enrollemnt
    • Number of admissions to the ER and cardiology wards of patients with AF
  • Rate or rhythm control strategy
    • Time Frame: Baselane study completion – average 1 week
    • Percentage of patients in rate or thythm control therapy
  • Antithrombotic strategies
    • Time Frame: Baselane study completion – average 1 week
    • Rate of use of oral antithrombotic strategies

Secondary Measures

  • Admission to the ER for atrial flutter
    • Time Frame: Enrollment
    • Number of admission to the ER for atrial flutter
  • Patients regularly followed up by the cardiology centers
    • Time Frame: 12 months
    • Rate of patients regularly followed up by the cardiology centers
  • Adherence to the 1A recommendations of current guidelines
    • Time Frame: 12 months
    • Rate of adherence to the 1A recommendations of current guidelines

Participating in This Clinical Trial

Inclusion Criteria

  • All patients with AF, admitted to cardiology wards for an urgent or planned hospitalization.
  • All patients admitted in a Day Hospital regimen for treatment of AF The diagnosis of AF must be confirmed by ECG.
  • Signed Patient Inform Consent.

Exclusion Criteria

  • The qualifying episode of AF was not documented with an ECG.
  • Age <18 years.
  • Patients with AF as a complication of an acute coronary syndrome (within 1 week from symptoms onset).
  • Patients with AF associated with cardiothoracic surgery (within 1 week from surgery).
  • Concomitant participation in other studies that can modify the diagnostic and/or therapeutic treatments.
  • Patients already enrolled in BLITZ-AF

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Heart Care Foundation
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Michele M Gulizia, MD, Study Chair, Heart Care Foundation

Citations Reporting on Results

Gulizia MM, Cemin R, Colivicchi F, De Luca L, Di Lenarda A, Boriani G, Di Pasquale G, Nardi F, Scherillo M, Lucci D, Fabbri G, Maggioni AP; BLITZ-AF Investigators. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study. Europace. 2019 Feb 1;21(2):230-238. doi: 10.1093/europace/euy166.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.